There were no differences in other parameters such as MMR protein expression status, tumor location, pre-operative CEA level, gross type, histologic diagnosis, T stage, lymphovascular invasion, mucin formation, Crohn-like reaction, or tumor budding. The gene discussed is CEACAM5; the disease is neoplasm.